We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Using an ecological momentary assessment to evaluate your digital health product.
Refreshed checklist of efficiency measures for more cost effective prescribing.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).